Efficacy of a Intervention to Reduce Medication Errors and Improve Adherence

Medication Adherence Clinical Trial

— ATEM-AP  

Official title:

Efficacy of a Intervention to Reduce Medication Errors and Therapeutic Failure in Patients Over 65 Years Polypharmacy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01291966
• Other study ID #: PI-0101/2008
• Status: Completed
• Phase: N/A
• First received: January 26, 2011
• Last updated: February 8, 2011
• Start date: January 2010
• Est. completion date: September 2010

Study information

• Verified date: December 2010
• Source: Hospital Universitario Reina Sofia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to demonstrate that an intervention based on the motivational interview directed to patients with polypharmacy to improve the Therapeutic Adherence and to reduce the errors of Medication in major measure that the habitual intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 154
• Est. completion date: September 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Patients with polypharmacy (5 or more medicines)

• That detects to them a problem of Therapeutic Adherence

• That agree to take part in the study

Exclusion Criteria:

• Immobilized patients or with an index of Barthel lower than 60 points

• Incapable to fulfill ABVD

• Patients with cognitive deterioration

• Patients with diagnosis of ictus in the last 6 months

• That has been admitted to hospital 2 or more times in the last year Institutionalized patients

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Medication Adherence
• Patient Compliance

Intervention

Behavioral:
• Motivational interview

Locations

Country	Name	City	State
Spain	Unidad Docente de Medicina Familiar y Comunitaria	Córdoba

Sponsors (3)

Lead Sponsor	Collaborator
Hospital Universitario Reina Sofia	Sociedad Andaluza de Medicina Familiar y Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	medication errors in the patients	Medication errors before and after the intervention in each group	Baseline, 1, 3 and 6 months	Yes
Secondary	Percentage of adherence	To measure adherence to treatment will use a combination of direct methods (counting of medication) and indirect tests are passed or self-reported compliance test Haynes-Sackett and Morisky-Green test	Baseline and 6 months	Yes